Companies › PYPD

POLYPID LTD (PYPD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001611842 · EDGAR filings · Updated 2026-07-21

POLYPID LTD (PYPD) has reported institutional ownership of 17.1%, with 19 institutional managers holding positions valued at $13.7M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-21 — Foreign issuer report (6-K) filed
• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-17 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, POLYPID LTD has 19 institutional holders and institutional ownership of 17.1%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 4 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

Jasper Therapeutics Inc (JSPR) · PASSAGE BIO INC COM NEW (PASG) · EDESA BIOTECH INC COM NEW (EDSA) · PALATIN TECHNOLOGIES INC (PTN) · Alpha Pro Tech Ltd (APT) · NRX PHARMACEUTICALS INC (NRXP)